Peptide Profiles
GH Peptide Blends: Sermorelin, Tesamorelin and Ipamorelin
What sermorelin/ipamorelin and tesamorelin/CJC-1295/ipamorelin blends contain, how to calculate each component, molar ratios and how blends are tested.
Peptide Profiles
What sermorelin/ipamorelin and tesamorelin/CJC-1295/ipamorelin blends contain, how to calculate each component, molar ratios and how blends are tested.
Comparisons
Sermorelin, tesamorelin and CJC-1295 act on the GHRH receptor; ipamorelin and MK-677 on the ghrelin receptor. How the two classes differ and compare.
Comparisons
Sermorelin acts on the pituitary growth hormone axis; GLP-1 and retatrutide act on gut hormone receptors. The comparison is between systems.
Comparisons
Sermorelin stimulates an axis; somatropin replaces its product. The difference in pulsatility, feedback and regulatory status, for research context.
Comparisons
Sermorelin acts at the top of the GH-IGF axis; IGF-1 LR3 is a modified version of the axis output. A comparison of upstream and downstream tools.
Comparisons
Hexarelin and GHRP-2 act at the ghrelin receptor; sermorelin and tesamorelin at the GHRH receptor. Why the two families are not interchangeable.
Comparisons
BPC-157 is studied as a locally acting repair peptide; sermorelin acts on a defined endocrine axis. The comparison turns on that difference.
Testing & Quality
Sermorelin is a 29-residue fragment that is easy to misidentify. The checks that distinguish it from its analogues using certificate data alone.
Lab Handling
Sermorelin is GHRH(1-29), a 29-residue peptide with a short measured half-life. Reconstitution maths, stability chemistry and storage practice.
Peptide Profiles
Sermorelin is GHRH (1-29), the shortest fragment of growth hormone-releasing hormone retaining receptor activity, with a literature going back to the 1980s.
Comparisons
Sermorelin and CJC-1295 act at the same receptor. The difference is degradation resistance and circulating duration, not mechanism. A side-by-side comparison.
Comparisons
Sermorelin is GHRH(1-29)-NH2; tesamorelin is full-length GHRH(1-44) with an N-terminal hexenoyl group. Structure, stability and clinical history compared.